CIPO Patents = 1

Forward Citations = 67

Loading Chart...

11 inventors (with patents filed for the assignee):

Robert Mischler (2 out of 2 patents)

Reinhard Gluck (2 out of 2 patents)

Martin Billeter (1 out of 7 patents)

4. Frank Radecke (1 out of 4 patents)

5. Henriette Schneider (1 out of 4 patents)

6. Pius Spielhofer (1 out of 4 patents)

7. Karin Kälin (1 out of 3 patents)

8. Thomas Hasler (1 out of 1 patent)

9. Emil Fürer (1 out of 1 patent)

10. Stefan Brantschen (1 out of 1 patent)

11. Reinhard Gl Uck (1 out of 1 patent)

12. Andre Collioud (3 patents)

13. Ulrich Gluck (0 patent)

5 patents: Sort by Forward Citations

1. 7402429 - Host cells comprising cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, further encoding antigenically active proteins (2008-07-22),

2. 6891037 - Method for the isolation of polysaccharides (2005-05-10),

3. 5879685 - Immunostimulating and immunopotentiating reconstituted influenza (1999-03-09),

4. 5565203 - Hepatitis A virus in a reconstituted influenza virosome and use as a (1996-10-15),

5. 5549896 - Hepatitis a virus strain, method for the isolation of new hepatitis a (1996-08-27),

Schweiz Serum & Impfinstitut Bern is a leading institute specializing in research, development, and production of serums and vaccines. With state-of-the-art facilities and a team of experts, we are dedicated to advancing healthcare through innovative solutions. Our commitment to quality and safety is reflected in the effectiveness of our products and services. Visit our website to learn more about our offerings and how we are shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#134 in

#1,653 in Switzerland

CH

Schweiz Serum & Impfinstitut Bern